CRISPR
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
CRISPR
Apr 28, 2024, 14:27 |
Blog
Michael D. : Meet the Master-Hands of Medicine
Michael D., Support Analyst at Sarah Cannon Research Institute, shared a post by Vivek Subbiah…
Apr 20, 2024, 01:23 |
Positive
Stuart H. Orkin was named one of TIME's 100 Most Influential People of 2024 - Dana-Farber News
Quoting Dana-Farber News on X/Twitter: "Congratulations to Dana-Farber Cancer Institute's Stuart H. Orkin, MD, who…
Apr 19, 2024, 13:34 |
Blog
Nicholas Restifo: When Nature is not enough
Nicholas Restifo, Co-founder and Chief Scientist at Marble Therapeutics, shared on Linkedin: “When Nature is…
Apr 5, 2024, 16:22 |
Career
Jun Kawashima: I recently transitioned to a new position as SVP, Head of Clinical Development at Function
Jun Kawashima, SVP, Head of Clinical Development at Function, shared on their LinkedIn: ''I’m happy…
Apr 5, 2024, 02:08 |
Blog
Vivek Subbiah: A real-life superhero
Vivek Subbiah shared on LinkedIn: “Want to meet a real-life superhero? Such a delight meeting Mike,…
Dec 5, 2023, 18:17 |
Blog
Feng Zhang: Thrilled to announce our latest exploration of CRISPR!
Feng Zhang, Investigator at the McGovern Institute for Brain Research at MIT, shared a post…
All:
6
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube